Full Refs for Educated Guess to Accepted Practice: the Use of Oral Anti-Diabetic Agents

Educated Guess to Accepted Practice: The Use of Oral Anti- Diabetic Agents in Pregnancy Oded Langer, MD, PhDPlease note: This is the complete reference list for the above article found on page 959 in the print journal. For your convenience, a few of these references have been listed in the article, too.REFERENCES1. Piacquadio K, Hollingsworth DR, Murphy H: Effects of in-utero exposure to oral hypoglycemic drugs. The Lancet 338:866-869, 1991 2. Kemball ML, McIvert C, Milner RDG, et al. Neonatal hypoglycemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child 1970;45:696-701. 3. Langer, O., Conway, D.L., Berkus, M.D., et al. A Comparison Glyburide and Insulin in Women with Gestational Diabetes Mellitus. New England Journal of Medicine, Vol. 343(16):1134-38, 2000. 4. Reece EA, Homko C, Miodovnik M, et al. A consensus report of the diabetes in pregnancy study group of North America Conference. J Maternal-Fetal Neonatal Med. 2002;12:362–3645. Metzger BE, Buchanan TA, Coustan DR, de Leivia A, et al. Summary and Recommendations of the Fifth International Workshop – Conference on Gestational Diabetes Mellitus. Diabetes Care. July 2007; 30, ProQuest Medical Library pg. S251.6. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol. 2003;102:857–868 and Greene MF. Oral hypoglycemic drugs for gestational diabetes [editorial]. N Engl J Med. 2000;343:1178–1179 7. Greene MF. Oral hypoglycemic drugs for gestational diabetes [editorial]. N Engl J Med. 2000;343:1178–11798. Koren G. The use of glyburide in gestational diabetes: an ideal example of “bench to bedside.” Pediatr Res. 2001;49:734 9. Saade G. Gestational diabetes mellitus: a pill or a shot? [ editorial] Obstet Gynecol. 2005;105:456–457 10. Durnwald C, Landon MB. Glyburide: The new alternative for treating gestational diabetes? [editorial] Am J Obstet Gynecol 2005; 193, 1-2.11. Catalano PM, Tyzbit ED, Wolfe RR, et al: Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264:E60-67, 199712. Langer O. The diabetes in pregnancy dilemma. Leading change with proven solutions. University Press of America 200613. Pendergrass M, Fazioni E, DeFronzo RA: Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus: same disease, another name? Diab Reviews 3:566-583, 199514. UK prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes 1995; 44:1249-58. 15. American Diabetes Association: Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 23:S27-31, 2000 (suppl 2)16. Lebovitz HE. Insulin secretagogues: old and new. Diabetes Rev 1999. 7:139-53 17. Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 25:1862-68, 2002 18. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high risk Hispanic women. Diabetes 51:2796-2803, 200219. DeFronzo RA, Simonson DC. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals. Diabetes Care 1984;7:72-80.20. Rossetti L, Giaaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13:610-3021. Simonson DC, Farrannini E, Bevilacqua S, et al. Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes Care 1984;33:838-45 22. Zharikova O, Ravindran S, Nanovskaya T, et al. The kinetics for glyburide metabolism by human and baboon livers and placentas. Am J obstet Gynecol 2006; 195(6): S185 (Abs).23. Yogev Y, Ben-Haroush A, Chen R, et al. Undiagnosed asymptomatic hypoglycemia: Diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004; 104:88-9324. Krentz AJ, Bailey CJ. Oral Antidiabetic Agents: Current role in type 2 diabetes mellitus. Drugs 2005; 65(3):385-411 25. Turner RC, Cull CA, Fright V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies. J Am Med Assoc 1999; 281:2005-1226. Krentz AJ, Bailey CJ, Melander A. Thiazolidinediones for type 2 diabetes. BMJ 2000; 321:252-3 27. Yki-Jarvinen H Thiazolidinedions. N Engl J Med 2004; 351:1106-1828. Lebovitz HE. α-Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Revs 1998; 6:132-4529. Cortez J, Tarsa M, Agent S, et al. Randomized controlled trial of acarbose vs. placebo in the treatment of gestational diabetes. Am J Obstet Gynecol 2006; 195(6):S149 (Abs).30. Enders AC, Blakenship TN: Comparative placental structure. Adv Drug Del Rev 38:3-16, 199931. Benirschke K, Kaufmann P, Baergen R. Human Placenta. Springer, New York 200632. Elliot B, Langer O, Schenker S, et al: Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 165:807-812, 1991 33. Elliot B, Schenker S, Langer O, et al: Comparative placental transport of oral hypoglycemic agents. A model of human placental drug transfer. Am J Obstet Gynecol 171:653-660, 199434. Elliot B, Langer O, Schussling F. A model of human placental drug transfer. Am J Obstet Gynecol 1997;176:527-30 35. Koren G: Glyburide and fetal safety: transplacental pharmacokinetic considerations. Reprod Toxicol 15:225-229, 200136. Nanovskaya TN, Nekhayeva, Hankins G, et al. (2006). Effect of human serum albumin on transplacental transfer of glyburide. Biochemical Pharmacology 72; 632-9 37. Kraemer J, Klein J, Lubetsky A, et al. Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety. (2006). Am J Obstet Gynecol 195, 270-4. 38. Gedeon C, Behravan J, Koren G, et al. Transport of glyburide by placental ABD Transporters: Implications in fetal drug exposure. Placenta 2006. 27; 109639. Langer O. Oral hypoglycemic agents and the pregnant diabetic: “From bench to bedside.”Seminars in Perinat 2002; 26(3):215-24. 40. Langer O. Oral hypoglycemic agents in pregnancy: Their time has come. J Maternal-Fetal and Neonatal Med 2002; 12: 376-83 41. Langer O. Oral Anti-Hyperglycemic Agents for the Management of Gestational Diabetes Mellitus. Obstet Gynecol Clin N Am. 34 (2007) 255- 274. 42. Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, et al. Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol 2006; 195:1081-543. Kovo M, Haroutiunian S, Feldman N, et al. Determination of metformin transfer across the human placenta using dually perfused ex-vivo placental cotyledon model. [abstract] Am J Obstet Gynecol December 2005;193(6): S8544. Hague WM, Davoren PM, McIntyre D, et al. Metformin crosses the placenta: a modulator for fetal insulin resistance? BMJ 2004; 327:880-1 45. Vavky E, Zahlsen K, Spigset O, et al. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005; 83:1575-846. Hale TW, Kristensen JH, Hacket LP, et al. Transfer of metformin into human milk. Diabetologia 2002; 45:1509-1447. Gardiner SJ, Kirkpatrick CM, Begg EJ, et al. Transfer of metformin into human milk. Clin Pharmacol Therap 2003; 73: 71-7.) 48. Sevillano J, Lopez-Perez IC, Herrera E, et al. Englitazone administration to late pregnant rats produces delayed body growth and insulin resistance in their fetuses and neonates. Biochem J 2005; 389, 913-849. Chan LYS, Yeung JH, Lau TK. Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril 2005; 83(4):955-850. Holmes HJ, Casey BM, Bawdon RE. Placental transfer of rosiglitazone in the ex vivo human perfusion model. Am J Obstet Gynecol 2006; 195, 1715-9 51. Patrikeeva S, Hemauer S, Nanovskaya T, Hankins G, Mahmoud A. Transplacental transfer and distribution of rosiglitazone. Am J Obstet Gynecol 2006; 195(6); S128 (Abs.) 52. Notelowitz M. Sulfonylurea therapy in the treatment of the pregnant diabetic. S A Med J 1971; 45:226-953. Towner D, Kjos SL, Montoro MM, et al: Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 18:1446-1451, 1995 54. Langer O, Conway D, Berkus M, et al. There is no association between hypoglycemic use and fetal anomalies. Am J Obstet Gynecol 1999; 180(1) (Abst): S38 55. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil and Steril 2006; 86(3):658- 63 56. Glueck et al (Glueck CJ, Wang P, Kobayashi S, et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 520-557. Jakubwicz DJ, Iuorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrin Metab 2002; 87:524-958. Moore L, Clokey D, Briery C, et al. Metformin use in gestational diabetes: efficacy and maternal and neonatal outcomes. Am J Obstet Gynecol 2006; 195(6); S142 (Abs.)59. Langer, O. Conway, D.L.: Level of Glycemia and Perinatal Outcome in Pregestational Diabetes. Journal of Maternal-Fetal Medicine. Vol 9, (1):35-41; Aug 2001 60. Langer O. A Spectrum of Glucose Thresholds May Effectively Prevent Complications in The Pregnant Diabetic Patient. Seminars of Perinatology vol. 26; no. 3 (June) 2002: pp 196-205 61. Langer O, Rodriguez DA, Xenakis EMJ, et al: Intensified vs. conventional management of gestational diabetes. Am J Obstet Gynecol 170:1036- 1047, 199462. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycemic agents in 118 diabetic pregnancies. Diabetic Med 2000; 17:507-1163. Lim JM, Tayob Y, O'Brien PM, et al. A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin. Med J Malaysia. 1997;52(4):377-8164. Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med. 2004; 15(1):51-565. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol. 2004; 190(5):1438-966. Chmait R, Dinise T, Moore T.: Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinat 2004;24:617-22 67. Gilson G, Murphy N. Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaskan native women. Am J Obstet Gynecol 2002, 187;6, S15268. Velazquez MD, Bolnick J, Cloakey D. The use of glyburide in the management of gestational diabetes. Obstet & Gynecol 2003; 101 (4) suppl. 88S69. Kahn BF, Davies JK, Lynch AM, et al. Predictors of glyburide failure in the treatment of gestational diabetes. Obst & Gynecol 107(6); 2006; 1303-0970. Jacobson GF, Ramos G, Ching J, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol (2005); 193, 118-2471. Bertini AM, Silva JC, Taborda W, et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med (2005); 33; 519 72. Rochon M, Rand L, Roth L, et al. Glyburide for the management of gestational diabetes: Risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol (2006); 195, 1090-473. Langer O, Most O, Monga S. Glyburide: Predictors of treatment failure in Gestational Diabetes. Am J Obstet Gynecol 2006; 195(6); S136 (Abs.) .74. Langer, O, Yogev, Y, Xenakis, E , et al: Insulin and glyburide therapy: Dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol. 2005 Jan;192(1):134-9.75. Langer O, Yogev Y, Xenakis E, et al. Overweight and obese in gestational diabetes: The impact on pregnancy outcome. Am J Obstet Gynecol (2005). 192, 1768-7676. Langer O, Monga S, Most O. Obese gestational diabetic women: Comparison of insulin and glyburide therapies. Am J Obstet Gynecol 2006; 195(6); 136S (Abs.). 77. Goetzel L, Wilkins I. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J Perinatol. 2002;22:403– 406.

Full Refs for Educated Guess to Accepted Practice: the Use of Oral Anti-Diabetic Agents

Details

Download

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

Support